Cytokinetics Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
CYTK chart
What traders are saying about $CYTK
Latest postsCytokinetics Inc news
- Mid-cap biotech catalysts: FDA dates, earnings, and pipeline data to watch
Yahoo Finance ·
- Cytokinetics presents new aficamten data across HCM patient types
StreetInsider ·
- Cytokinetics presents new data on aficamten for heart condition By Investing.com
Investing.com Canada ·
- Cytokinetics Announces Additional Data Related to Aficamten Presented at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026
Yahoo Finance ·
- Temporary heart-function drops affected 12 of 410 patients; none were linked to heart-failure stays or deaths.
Stock Titan ·
- Cytokinetics, Incorporated (NASDAQ:CYTK) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
Simply Wall St ·
- FDA Decision Watch: Summit’s Lung Cancer Drug, Cytokinetics’ Heart Therapy And Teva’s Igalmi In Spotlight This Week
stocktwits.com ·
- Cytokinetics, Incorporated 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:CYTK) 2026-11-08
Seeking Alpha ·
- What Cytokinetics (CYTK)'s MYQORZO Launch Means For Shareholders
Simply Wall St ·
- Cytokinetics, Incorporated (CYTK) stock price, news, quote and history
Yahoo Finance Australia ·
- Cytokinetics (CYTK) Stock Looks Hard To Judge On Book Value
Simply Wall St ·
- Citigroup maintains Cytokinetics at Buy, raises price target to $105 from $99
TradingView ·
Cytokinetics Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $88.0M | $18.5M | $7.5M | $94.6M |
| Net income | -$785.0M | -$589.5M | -$526.2M | -$389.0M |
| Diluted EPS | $-6.54 | $-5.26 | $-5.45 | $-4.33 |
| Total assets (year end) | $1.42B | $1.40B | $824.3M | $1.01B |
| Cash and equivalents (year end) | $122.5M | $94.9M | $113.0M | $65.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cytokinetics Inc
- Ticker
- CYTK (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Fiscal year end
- December 31
- SEC CIK
- 1061983
Frequently asked questions
What exchange is Cytokinetics Inc listed on?
Cytokinetics Inc trades on the Nasdaq under the ticker symbol CYTK.
What industry is Cytokinetics Inc in?
Cytokinetics Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Cytokinetics Inc headquartered?
Cytokinetics Inc's business address on file with the SEC is in South San Francisco, CA.
When does Cytokinetics Inc's fiscal year end?
Cytokinetics Inc's fiscal year ends on December 31.
How much revenue did Cytokinetics Inc report?
Cytokinetics Inc reported $88.0M in revenue for calendar year 2025, according to its SEC filings.